Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 24,894 | 16,309 | 14,096 | 17,031 | 8,650 |
| Operating Income | -24,894 | -16,309 | -14,096 | -17,031 | -8,650 |
| Other Income | 498 | 16 | -40 | -4 | -31 |
| Pre-tax Income | -24,397 | -16,293 | -14,136 | -17,036 | -8,681 |
| Income Tax | 183 | 88 | 60 | 81 | 124 |
| Net Income Continuous | -24,580 | -16,381 | -14,197 | -17,117 | -8,805 |
| Net Income | $-24,580 | $-16,381 | $-14,197 | $-17,117 | $-8,805 |
| EPS Basic Total Ops | -0.27 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Basic Continuous Ops | -0.27 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Diluted Total Ops | -0.27 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Diluted Continuous Ops | -0.27 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.18 | -0.16 | N/A | N/A |
| EBITDA(a) | $-24,663 | $-16,085 | $-14,096 | $-17,025 | $-8,648 |